A number of other institutional investors have also made changes to their positions in the business. Wynn Capital LLC boosted its holdings in GE HealthCare Technologies by 4.1% in the 1st quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock valued at $284,000 after purchasing an additional 122 shares during the period. Byrne Asset Management LLC lifted its stake in shares of GE HealthCare Technologies by 0.8% in the first quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock valued at $1,493,000 after buying an additional 126 shares during the period. Fiduciary Trust Co grew its position in GE HealthCare Technologies by 1.8% during the fourth quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock worth $595,000 after buying an additional 133 shares in the last quarter. WASHINGTON TRUST Co increased its stake in GE HealthCare Technologies by 7.7% during the first quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock valued at $168,000 after acquiring an additional 133 shares during the period. Finally, Quent Capital LLC raised its holdings in GE HealthCare Technologies by 21.3% in the 1st quarter. Quent Capital LLC now owns 780 shares of the company’s stock valued at $71,000 after acquiring an additional 137 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on GEHC. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Mizuho decreased their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, May 1st. Bank of America lowered their price target on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Stifel Nicolaus initiated coverage on shares of GE HealthCare Technologies in a report on Tuesday, August 6th. They set a “buy” rating and a $100.00 price objective for the company. Finally, The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price on the stock. Five analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $95.00.
Check Out Our Latest Stock Report on GE HealthCare Technologies
GE HealthCare Technologies Trading Down 0.6 %
Shares of GEHC stock opened at $84.80 on Monday. The company has a market capitalization of $38.71 billion, a P/E ratio of 24.80, a P/E/G ratio of 3.00 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. The firm has a 50-day moving average price of $79.90 and a 200 day moving average price of $83.16.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. The company had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. GE HealthCare Technologies’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.92 earnings per share. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.
Insider Transactions at GE HealthCare Technologies
In related news, CTO Taha Kass-Hout sold 3,300 shares of GE HealthCare Technologies stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.
GE HealthCare Technologies Company Profile
(Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
Receive News & Ratings for GE HealthCare Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for GE HealthCare Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
link